Research ArticleDepression

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

See allHide authors and affiliations

Science Translational Medicine  09 Jun 2021:
Vol. 13, Issue 597, eabe1376
DOI: 10.1126/scitranslmed.abe1376

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine